prednisolone has been researched along with Labhart-Willi Syndrome in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuramochi, Y | 1 |
| Kato, T | 1 |
| Sudou, M | 1 |
| Sugano, H | 1 |
| Takagi, H | 1 |
| Morita, T | 1 |
1 other study available for prednisolone and Labhart-Willi Syndrome
| Article | Year |
|---|---|
Cardiac tamponade due to systemic lupus erythematosus in patient with Prader-Willi syndrome after growth hormone therapy.
Topics: Adolescent; Cardiac Tamponade; Drainage; Drug Administration Schedule; Echocardiography; Female; Glu | 2007 |